首页> 美国卫生研究院文献>BMC Family Practice >Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT)
【2h】

Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT)

机译:POINT研究的设计:通过在基层医疗团队(POINT)中整合一名非配药药剂师来优化药物治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn the Netherlands, 5.6 % of acute hospital admissions are medication-related. Almost half of these admissions are potentially preventable. Reviewing medication in patients at risk in primary care might prevent these hospital admissions. At present, implementation of medication reviews in primary care is suboptimal: pharmacists lack access to patient information, pharmacists are short of clinical knowledge and skills, and working processes of pharmacists (focus on dispensing) and general practitioners (focus on clinical practice) match poorly. Integration of the pharmacist in the primary health care team might improve pharmaceutical care outcomes.The aim of this study is to evaluate the effect of integration of a non-dispensing pharmacist in general practice on the safety of pharmacotherapy in the Netherlands.
机译:背景在荷兰,有5.6%的急性医院入院与药物有关。这些准入中几乎有一半是可以预防的。在具有初级保健风险的患者中复查药物可能会阻止这些住院。目前,在初级保健中对药物审查的实施情况欠佳:药剂师无法获取患者信息,药剂师缺乏临床知识和技能,药剂师(侧重于配药)和全科医生(侧重于临床实践)的工作流程不尽如人意。将药剂师整合到初级保健团队中可能会改善药物护理结果。本研究的目的是评估在荷兰的常规实践中,非配药师的整合对药物治疗安全性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号